If you've ever stood in front of the refrigerator at 10pm—knowing you're not hungry but somehow unable to walk away—you understand what people mean by "food noise."
It's that constant background hum of food thoughts. What to eat. When to eat. Whether you should eat. The negotiation with yourself about whether one more snack really matters. The mental exhaustion of fighting cravings that seem to have a mind of their own.
You've probably tried willpower. It doesn't work long-term—and that's not a personal failure. Your brain chemistry is literally working against you. The same serotonin pathways that regulate mood and sleep also control satiety and food reward. When they're out of balance, your brain keeps asking for food even when your body doesn't need it.
This is where 5-HTP enters the conversation. It's the direct precursor to serotonin—the neurotransmitter that tells your brain "I've had enough." And interestingly, it targets the same downstream pathway that medications like Ozempic work on, just through a different mechanism.
Let's be clear upfront: 5-HTP won't produce Ozempic-level weight loss. We're talking about 5% body weight, not 15%. But for people whose weight struggles are driven by constant food thoughts and carbohydrate cravings—rather than metabolic issues—it offers an accessible, affordable starting point.
What Is "Food Noise"?
"Food noise" isn't a clinical term—it emerged from patients describing their experience on GLP-1 medications like Ozempic and Wegovy. But it captures something real: the intrusive, persistent thoughts about food that some people experience throughout the day.
As one patient described it to Canadian media: "You're just constantly thinking about food and not having enough, having too much, 'what am I gonna eat? Oh, don't add in the carbs because carbs aren't good.'" The mental load becomes exhausting.
Neurologically, this likely involves two distinct systems:
- Homeostatic hunger — regulated by the hypothalamus, particularly POMC and AgRP neurons that respond to energy status signals from your body
- Hedonic drive — regulated by dopamine reward circuits in the ventral tegmental area (VTA), responsible for the "wanting" aspect of food—the pull toward pleasurable eating even when you're not hungry
Research published in Molecular Psychiatry (2021) demonstrates that serotonin neurons project to both these systems through distinct pathways. The arcuate nucleus pathway (via 5-HT2C and 5-HT1B receptors) regulates hunger-driven eating. The VTA pathway regulates non-hunger-driven, reward-based eating.
5-HTP, as the immediate precursor to serotonin, provides raw material for both pathways. This dual action may explain why some users report not just eating less, but actually thinking about food less.
How 5-HTP Affects Appetite: The Serotonin-GLP-1 Connection
Here's what most articles miss: 5-HTP and GLP-1 drugs aren't just different approaches to the same problem. Their mechanisms actually converge—and may even amplify each other.
The POMC Convergence Point
A landmark 2002 study in Science demonstrated that 5-HT2C receptors are co-expressed with POMC (proopiomelanocortin) neurons in the arcuate nucleus of the hypothalamus (Heisler et al., 2002). When serotonin activates these receptors, POMC neurons release α-MSH, which acts on melanocortin-4 receptors to suppress appetite.
Here's the key insight: GLP-1 drugs also activate POMC neurons—just through a different receptor (the GLP-1 receptor). The pathways converge at the same endpoint.
But it goes deeper. A 2021 paper in the International Journal of Molecular Sciences revealed a bidirectional relationship:
- GLP-1 receptor agonists stimulate serotonin release from gut cells
- Serotonin, in turn, enhances GLP-1 release from intestinal L-cells
Source: Zhang et al., Int J Mol Sci, 2021
This raises an intriguing possibility: 5-HTP supplementation might not just produce independent effects, but could potentially enhance your body's own GLP-1 signaling. This hasn't been tested in human trials yet, but the mechanistic foundation is there.
Beyond Serotonin: Ghrelin and CCK
Serotonin's appetite effects extend beyond the brain. In the gut, 5-HTP influences two critical hunger hormones:
Ghrelin (the "hunger hormone"): Animal studies show that 5-HTP administration reduces ghrelin expression in the stomach and lowers plasma ghrelin levels (Zhang et al., 2007). Lower ghrelin means fewer hunger signals reaching your brain between meals.
Cholecystokinin (CCK): This satiety hormone is released when you eat, signaling fullness. Research has identified neurons that co-express both CCK and serotonin receptors (Máté et al., 2013), suggesting 5-HTP may amplify post-meal satisfaction signals. This may explain why clinical trial participants consistently report "early satiety"—feeling full sooner during meals.
Why Lorcaserin Validates the Mechanism
The serotonin approach to weight loss isn't theoretical speculation. Lorcaserin (brand name Belviq) was an FDA-approved selective 5-HT2C receptor agonist that produced clinically meaningful weight loss in large trials. It was voluntarily withdrawn in 2020 due to a slightly elevated cancer risk found in long-term monitoring—not because the mechanism didn't work.
5-HTP doesn't directly activate 5-HT2C receptors the way lorcaserin did. It provides serotonin, which then activates multiple receptor subtypes. This is less targeted but potentially gentler, with a much longer safety track record for the compound itself.
Clinical Trial Evidence
The research on 5-HTP and weight loss spans three decades. Here's what controlled trials actually demonstrate:
The Cangiano Studies (1992, 1998)
Cangiano et al., 1992 (American Journal of Clinical Nutrition): 20 obese patients were randomized to 900mg/day 5-HTP or placebo for 12 weeks. During the first 6 weeks with no dietary restrictions, the 5-HTP group lost 1.7kg vs essentially nothing in placebo. During the second 6 weeks with a 1,200-calorie diet prescribed, the 5-HTP group lost an additional 3.3kg.
Critical finding: The 5-HTP group spontaneously reduced carbohydrate intake by approximately 50% and consistently reported earlier satiety—feeling full faster.
Cangiano et al., 1998 (International Journal of Obesity): 25 overweight adults with Type 2 diabetes took 750mg/day 5-HTP or placebo for 2 weeks. The 5-HTP group reduced caloric intake by approximately 435 calories/day—primarily from carbohydrates—and lost about 2kg vs no change in placebo.
The Evans Study (2023) — Most Recent
This study takes a different approach that's particularly interesting:
Evans et al., 2023 (Journal of Dietary Supplements): 48 exercise-trained adults were randomized to just 100mg/day 5-HTP or placebo for 8 weeks. Crucially, participants were instructed not to change their eating habits and tracked food intake via app.
Fat mass decreased significantly in the 5-HTP group (p = 0.02) with no change in placebo—despite no changes in caloric intake. The 5-HTP group lost approximately 0.8kg (1.8 lbs) of fat while placebo showed a slight gain.
This suggests 5-HTP may affect body composition through mechanisms beyond simple appetite suppression—possibly through effects on metabolism or fat oxidation. However, this was a small, preliminary study that needs replication.
All Trial Data Summary
| Study | Participants | Dose | Duration | Key Result |
|---|---|---|---|---|
| Cangiano 1992 | 20 obese adults | 900mg/day | 12 weeks | ~5kg loss vs 0.9kg placebo |
| Cangiano 1998 | 25 diabetic adults | 750mg/day | 2 weeks | ~435 kcal/day reduction |
| Ceci 1989 | 19 obese women | ~8mg/kg/day | 5 weeks | 1.4kg loss, reduced intake |
| Rondanelli 2009 | 27 overweight women | Sublingual spray | 8 weeks | Increased satiety, reduced BMI |
| Evans 2023 | 48 trained adults | 100mg/day | 8 weeks | ~0.8kg fat loss (no diet change) |
- Most trials are small (19-48 participants)
- The most-cited studies (Cangiano) are from the 1990s
- Many trials come from the same research group
- No trials longer than 12 weeks
- No direct head-to-head trials against GLP-1 drugs
- No large Phase 3 trials like Wegovy/Zepbound have
The evidence is promising but not definitive. If you need to lose significant weight (50+ lbs) and have access to GLP-1 medications, those have much stronger evidence.
How Long Does It Take for 5-HTP to Work?
One of the most common questions—and competitors rarely answer it clearly. Here's what to realistically expect:
Track your carbohydrate cravings specifically, not just weight. If 5-HTP is working, you'll likely notice reduced desire for bread, pasta, sweets, and chips before you see scale changes. This is your early signal.
Food Noise Score: Self-Assessment
Not everyone experiences food noise equally, and 5-HTP doesn't work for everyone. This assessment helps identify whether your eating patterns suggest the serotonin-mediated appetite dysregulation that 5-HTP targets.
5-HTP vs GLP-1 Drugs: Honest Comparison
Let's be direct about what 5-HTP can and can't do compared to medications like Ozempic, Wegovy, Mounjaro, and Zepbound.
| Factor | 5-HTP | GLP-1 Drugs |
|---|---|---|
| Weight Loss | ~5% body weight | ~15% body weight |
| Mechanism | Serotonin → 5-HT2C → POMC | GLP-1R → multiple pathways |
| Monthly Cost | $15-40 (OTC) | $1,000+ (often insurance-dependent) |
| Administration | Oral capsule, daily | Weekly injection (or daily oral) |
| Prescription | No | Yes |
| Evidence Quality | Small trials, mostly 1990s | Large Phase 3 trials, recent |
| Side Effects | Nausea, GI upset (mild) | Nausea, vomiting, diarrhea (can be severe) |
| Availability | Widely available | Ongoing shortages |
| Best For | Carb cravers, emotional eaters, modest goals | Significant obesity, metabolic disease |
Bottom line: If you need to lose 50+ pounds and can access GLP-1 medications, they're dramatically more effective. If you're dealing with 10-20 pounds and constant carbohydrate cravings, 5-HTP is a reasonable, accessible first step. They're not really competitors—they're different tools for different situations.
5-HTP vs L-Tryptophan: Which Is Better?
Both are serotonin precursors, but they're not interchangeable:
| Factor | 5-HTP | L-Tryptophan |
|---|---|---|
| Conversion Steps | 1 step to serotonin | 2 steps to serotonin |
| Bioavailability | ~70% (direct absorption) | Competes with other amino acids |
| Effective Dose | 100-300mg for appetite | 500-2000mg for appetite |
| Food Timing | Works with or without food | Better without protein (competition) |
| Appetite Research | Multiple controlled trials | Less specific research for appetite |
| Cost | $15-30/month | $20-40/month |
| Sleep Benefits | Yes (converts to melatonin) | Yes (same pathway) |
For appetite suppression specifically: 5-HTP is generally preferred due to its direct conversion to serotonin, higher bioavailability, and more specific research for weight loss. L-tryptophan may be preferred for general mood support or if 5-HTP causes GI issues.
Don't combine 5-HTP and L-tryptophan—both increase serotonin and the combination could lead to excessive levels. Choose one or the other.
Dosage & Timing Protocol
Clinical trials used widely varying doses, from 100mg/day (Evans 2023) to 900mg/day (Cangiano 1992). Here's a practical approach:
When to Take 5-HTP: Timing Matters
- For appetite suppression: 30-45 minutes before meals (especially dinner)
- For evening snacking: Afternoon dose around 3-4pm
- For sleep + appetite: Single dose 30-45 minutes before bed
- For all-day coverage: Split doses (100mg morning + 100-200mg pre-dinner)
The Evans 2023 study showing body composition effects used just 100mg/day—higher isn't necessarily better. Start low, assess response, and only increase if needed.
How to Avoid 5-HTP Nausea
Nausea is the most common 5-HTP side effect, affecting up to 35% of users in some trials. It happens because about 95% of your body's serotonin is in the gut, not the brain—so increasing serotonin affects digestion.
Here's how to minimize it:
Most nausea resolves within 1-2 weeks as your body adjusts. If it persists beyond 2 weeks at low doses, 5-HTP may not be well-tolerated for you.
Who Responds Best to 5-HTP?
Based on the clinical trial data and mechanism of action, 5-HTP appears most effective for specific eating patterns:
Good Candidates
- Carbohydrate cravers — fMRI research shows 5-HTP specifically affects brain responses to carb-rich foods
- Emotional/stress eaters — serotonin's mood regulation may address the root cause
- Evening/night eaters — serotonin naturally declines in evening; supplementation may help
- High "food noise" individuals — constant food thoughts often reflect serotonin dysregulation
- People who feel calmer after eating carbs — suggests serotonin deficiency being self-medicated through food
- Those with Type 2 diabetes — the Cangiano 1998 study showed particular benefit in this population
- People with mild-moderate weight loss goals — 10-20 pounds, not 50+
Less Likely to Respond
- Metabolic obesity — if the issue is slow metabolism rather than overeating
- Protein/fat cravers — 5-HTP's effects are carb-specific
- Normal eating patterns with low activity — if appetite isn't the problem
- Severe binge eating disorder — may need more intensive clinical intervention
- Those already on SSRIs — cannot safely use 5-HTP
What Users Actually Report
Beyond clinical trials, here's what real users describe (sourced from Drugs.com reviews and health forums). Individual experiences vary significantly.
Positive Experiences
Negative or Mixed Experiences
User testimonials are not scientific evidence. People who have dramatic results (positive or negative) are more likely to post reviews, creating selection bias. Your experience may differ significantly. These are shared to illustrate the range of responses, not to promise specific outcomes.
Safety & Drug Interactions
Common Side Effects
In clinical trials and user reports, the most common side effects include:
- Nausea — most common, usually dose-dependent, often resolves with time
- GI upset — diarrhea, stomach discomfort, heartburn
- Drowsiness — serotonin converts to melatonin; some find it sedating
- Vivid dreams — likely related to increased REM sleep
- Headache — less common, usually temporary
Serious Interactions — Do Not Combine
- SSRIs — Prozac (fluoxetine), Zoloft (sertraline), Lexapro (escitalopram), Paxil (paroxetine), Celexa (citalopram)
- SNRIs — Effexor (venlafaxine), Cymbalta (duloxetine), Pristiq (desvenlafaxine)
- MAOIs — Nardil (phenelzine), Parnate (tranylcypromine), rarely used but dangerous
- Triptans for migraine — Sumatriptan (Imitrex), rizatriptan (Maxalt), others
- Tramadol — common pain medication with serotonergic effects
- Linezolid (Zyvox) — antibiotic with MAOI activity
- St. John's Wort, SAMe — supplements that affect serotonin
Serotonin syndrome is potentially life-threatening. Symptoms include agitation, rapid heart rate, high blood pressure, dilated pupils, muscle twitching, and fever. Seek emergency care if these occur.
Other Precautions
- Pregnancy/nursing: Insufficient safety data—avoid
- Surgery: Stop 2 weeks before due to potential interactions with anesthesia
- Liver disease: 5-HTP is metabolized hepatically; use caution
- Down syndrome: Has been linked to seizures in this population
- Carbidopa: Used for Parkinson's—may enhance 5-HTP effects unpredictably
If you take any psychiatric medication or have a psychiatric diagnosis, consult your prescriber before using 5-HTP.
Frequently Asked Questions
5-HTP crosses the blood-brain barrier within 1-2 hours. Most people notice reduced cravings within 3-7 days. Measurable weight changes typically appear at 4-8 weeks. Clinical trials showing significant weight loss ran for 8-12 weeks. If you notice nothing after 4 weeks at adequate doses, 5-HTP may not be effective for you.
For appetite suppression: 30-45 minutes before meals, especially dinner. For evening snacking: afternoon dose around 3-4pm. For sleep + appetite benefits: 30-45 minutes before bed. The dinner/evening timing is often most effective since that's when most people struggle with cravings.
Yes—this is actually where 5-HTP shows its strongest effects. The Cangiano studies found carbohydrate intake specifically was reduced by up to 50%. Brain imaging research (Ioannou 2017) showed 5-HTP increases satiety-related brain activity specifically when viewing carbohydrate-rich foods. The 5-HT2C receptor pathway is particularly sensitive to carbohydrate intake signals.
No. 5-HTP is not addictive and doesn't produce tolerance the way stimulant appetite suppressants do. However, some users report mild withdrawal effects (irritability, mood changes) if stopping abruptly after long-term use. Gradual tapering is recommended rather than sudden discontinuation.
Generally yes, but avoid combining with other serotonin-affecting supplements (St. John's Wort, SAMe, L-tryptophan). Combining with phosphatidylserine or huperzine A (as in FOG OFF) is generally considered safe—these work through different mechanisms. Always disclose all supplements to your healthcare provider.
Possibly, and usually positively. Serotonin is the "feel-good" neurotransmitter. Many users report improved mood, reduced anxiety, and better sleep alongside appetite effects. This can help break emotional eating cycles. However, if you have a mood disorder or take psychiatric medications, discuss with your healthcare provider first.
There's no direct contraindication, and the mechanisms may be complementary (both ultimately activate POMC neurons). However, this combination hasn't been studied in clinical trials. Both can cause GI side effects that might compound. Discuss with your prescribing physician before combining—don't self-experiment.
There's no definitive answer from research. Some practitioners recommend cycling (8 weeks on, 2 weeks off) to prevent theoretical receptor downregulation, though this hasn't been demonstrated in studies. Others suggest continuous use is fine. Practical approach: if effects diminish, try a 1-2 week break; if it continues working, continue using it.
Chemically, yes—5-HTP is 5-HTP regardless of source. Virtually all commercial 5-HTP is extracted from Griffonia simplicifolia seeds (a West African plant naturally high in the compound). There's no meaningful difference between brands in terms of the molecule itself, though purity and quality control can vary. Look for reputable brands with third-party testing.
The Evans 2023 study found reduced overall fat mass, but no study has specifically measured visceral (belly) fat. 5-HTP works by reducing appetite and carbohydrate cravings, which may indirectly reduce belly fat through overall calorie reduction—but it doesn't "target" belly fat. For visceral fat reduction, overall calorie deficit and exercise remain the primary tools.
The Evans 2023 study found fat loss without changes in caloric intake, suggesting possible metabolic effects beyond appetite suppression. However, this was a small preliminary study. Most evidence suggests 5-HTP primarily works through appetite reduction. Don't take it expecting thermogenic "fat burning"—it's an appetite suppressant, not a metabolic enhancer.
Based on clinical trials: approximately 5% of body weight over 8-12 weeks with consistent use. For a 180-pound person, that's about 9 pounds. Individual results vary significantly based on eating patterns, baseline food noise, and dose. This is modest compared to GLP-1 drugs (15%) but meaningful for people whose primary issue is carb cravings and emotional eating.
References
- Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr. 1992;56(5):863-867. PMID: 1384305
- Cangiano C, Laviano A, Del Ben M, et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients. Int J Obes Relat Metab Disord. 1998;22(7):648-654. PMID: 9705024
- Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transm. 1989;76(2):109-117. PMID: 2468734
- Evans C, Mekhail V, Curtis J, et al. The Effects of 5-HTP on Body Composition: An 8-Week Preliminary RCT. J Diet Suppl. 2023;20(4):621-630. PMID: 35583055
- Ioannou S, Williams AL. Preliminary fMRI findings concerning the influence of 5-HTP on food selection. Brain Behav. 2017;7(1):e00594. PMC5256178
- Heisler LK, Cowley MA, Tecott LH, et al. Activation of central melanocortin pathways by fenfluramine. Science. 2002;297(5581):609-611. PMID: 12142539
- Xu Y, Jones JE, Bhargava A, et al. 5-HT recruits distinct neurocircuits to inhibit hunger-driven and non-hunger-driven feeding. Mol Psychiatry. 2021;26(11):6690-6704. Nature
- Zhang T, Perkins MH, Chang H, et al. The Mechanism of Secretion and Metabolism of Gut-Derived 5-Hydroxytryptamine. Int J Mol Sci. 2021;22(15):7931. MDPI
- Birdsall TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev. 1998;3(4):271-280. PMID: 9727088
- Rondanelli M, Klersy C, Iadarola P, et al. Satiety and amino-acid profile in overweight women after a new treatment using a natural plant extract sublingual spray formulation. Int J Obes. 2009;33(10):1174-1182. PMID: 19752879
- Magnussen I, Nielsen-Kudsk F. Bioavailability and related pharmacokinetics in man of orally administered L-5-hydroxytryptophan in a steady state. Acta Pharmacol Toxicol. 1980;46(4):257-262. PMID: 6966118
- Westenberg HG, Gerritsen TW, Meijer BA, van Praag HM. Kinetics of l-5-hydroxytryptophan in healthy subjects. Psychiatry Res. 1982;7(3):373-385. PMID: 6187038
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. (STEP 1 trial)
- Liu D, Zhu H, Guo Y, et al. The 5-HT-related gut-brain axis in obesity. Life Sciences. 2024;355:123016.
- Wang J, Wang N, Bhargava A. Unraveling the serotonin saga: from discovery to weight regulation and beyond. Cell Biosci. 2023;13:147.
- Perez CI, et al. The Triple Combination Phentermine Plus 5-HTP/Carbidopa Leads to Greater Weight Loss. Front Pharmacol. 2019;10:1327. PMC6851240
- Zhang H, Yin J, Li D, et al. Tryptophan enhances ghrelin expression and secretion associated with increased food intake and weight gain in weanling pigs. Domest Anim Endocrinol. 2007;33(1):47-61. PMID: 16650710
- Máté Z, Poles MZ, Szabó G, et al. Spatiotemporal expression pattern of DsRedT3/CCK gene construct during postnatal development of myenteric plexus in transgenic mice. Cell Tissue Res. 2013;352(2):199-206. PMID: 23397427
